Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674508 | SCV000799855 | likely pathogenic | Glycogen storage disease type III | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000674508 | SCV004215268 | likely pathogenic | Glycogen storage disease type III | 2023-06-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000674508 | SCV004529243 | pathogenic | Glycogen storage disease type III | 2024-02-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr1117*) in the AGL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGL are known to be pathogenic (PMID: 19299494). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with AGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 558267). For these reasons, this variant has been classified as Pathogenic. |